Stockreport

Daiichi Sankyo posts positive DS-9606 clinical trial results in solid tumours [Yahoo! Finance]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF of the first-in-human Phase I trial of its investigational antibody drug conjugate (ADC) DS-9606 for treating advanced solid tumours. Developed in collaboration with t [Read more]